查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620557

脑膜炎诊断测试市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Meningitis Diagnostic Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球脑膜炎诊断测试市场于 2023 年达到 1.195 亿美元，预计 2024 年至 2032 年复合年增长率为 3.5%。引入创新的治疗解决方案。对快速、精确诊断的需求不断增长，激发了人们对聚合酶炼式反应 (PCR) 检测和新一代定序 (NGS) 等先进检测方法的兴趣。这些技术提供了更高的准确性和速度，使医疗保健专业人员能够从脑脊髓液样本中识别病原体的遗传物质。此外，抗生素和疫苗等改进治疗方案的开发可以改善患者的治疗效果并有助于市场的扩张。

关注脑膜炎意识的公共卫生措施和教育计画也在推动成长方面发挥重要作用。脑膜炎诊断检测市场可依检测类型分类，包括乳胶凝集检测、侧流检测、PCR检测、酵素连结免疫吸附检测（ELISA）、培养检测和其他方法。 PCR 检测领域尤其突出，由于其卓越的准确性、灵敏度和快速结果，到 2023 年已达到 4,220 万美元。按年龄组分析市场时，婴儿占有很大份额，到 2023 年将占 39.4%。

此年龄层的检测通常涉及血液培养和 PCR 检测，凸显了快速、灵敏的方法对于减少潜在併发症的重要性。北美脑膜炎诊断检测市场预计将以 3.3% 的复合年增长率成长，到 2032 年将达到 7,370 万美元。常见的诊断技术包括 PCR、侧流检测和培养测试，所有这些技术都可以快速、准确地鑑定细菌和病毒株。此外，政府主导的疫苗接种计划和诊断能力的进步，以及脑膜炎病例的显着增加，正在推动市场向前发展。诊断检测产业有望稳定成长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 1.195 亿美元
预测值 1.619 亿美元
复合年增长率 3.5%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球脑膜炎发生率上升
      • 分子诊断技术的进步
      • 提高早期诊断和治疗意识
    • 产业陷阱与挑战
      • 先进诊断测试的高成本
      • 诊断工具获得严格的监管批准
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按测试类型，2021 - 2032 年

  • 主要趋势
  • 乳胶凝集试验
  • 侧流层析
  • PCR检测
  • 酵素连结免疫吸附试验
  • 文化测试
  • 其他测试类型

第 6 章：市场估计与预测：按年龄划分，2021 - 2032

  • 主要趋势
  • 婴儿
  • 孩子们
  • 青少年
  • 年轻人
  • 成年人

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 诊断中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章：公司简介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux
  • Bio-Rad Laboratories
  • Certest Biotec
  • ELITechGroup
  • F. Hoffmann-La Roche
  • IMMY
  • Seegene
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Uniogen
简介目录
Product Code: 11874

The Global Meningitis Diagnostic Testing Market reached USD 119.5 million in 2023 and is anticipated to grow at a CAGR of 3.5% from 2024 to 2032. This growth is driven by several critical factors, including the rising incidence of meningitis, advancements in diagnostic technologies, and the introduction of innovative therapeutic solutions. The increasing demand for swift and precise diagnosis has spurred interest in advanced testing methods, such as polymerase chain reaction (PCR) assays and next-generation sequencing (NGS). These technologies offer heightened accuracy and speed, allowing healthcare professionals to identify the genetic material of pathogens from cerebrospinal fluid samples. Additionally, the development of improved treatment options, such as antibiotics and vaccines, enhances patient outcomes and contributes to the market's expansion.

Public health initiatives and educational programs focused on meningitis awareness also play a significant role in driving growth. The meningitis diagnostic testing market can be categorized by test type, including latex agglutination tests, lateral flow assays, PCR assays, enzyme-linked immunosorbent assays (ELISA), culture tests, and other methods. The PCR assay segment is particularly prominent, having reached USD 42.2 million in 2023 due to its exceptional accuracy, sensitivity, and rapid results. When analyzing the market by age group, infants represent a substantial share, accounting for 39.4% share in 2023. This demographic is especially vulnerable to meningitis, necessitating early and effective diagnostic approaches to address the risks associated with bacterial infections.

Testing for this age group often involves blood cultures and PCR tests, highlighting the importance of quick and sensitive methodologies to reduce potential complications. The North American meningitis diagnostic testing market is expected to grow at 3.3% CAGR, reaching USD 73.7 million by 2032. The U.S. market benefits from a robust healthcare infrastructure, heightened awareness of meningitis, and increased healthcare investments. Common diagnostic techniques include PCR, lateral flow assays, and culture tests, all of which provide rapid and precise identification of bacterial and viral strains. Moreover, government-led vaccination initiatives and advancements in diagnostic capabilities, alongside a notable rise in meningitis cases, are propelling the market forward.Overall, the meningitis diagnostic testing sector is poised for steady growth, driven by technological innovations and a heightened focus on effective healthcare solutions.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$119.5 Million
Forecast Value$161.9 Million
CAGR3.5%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of meningitis globally
      • 3.2.1.2 Technological advancements in molecular diagnostics
      • 3.2.1.3 Increasing awareness about early diagnosis and treatment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of advanced diagnostic tests
      • 3.2.2.2 Stringent regulatory approvals for diagnostic tools
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Latex agglutination tests
  • 5.3 Lateral flow assay
  • 5.4 PCR assay
  • 5.5 ELISA tests
  • 5.6 Culture test
  • 5.7 Other test types

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Infants
  • 6.3 Children
  • 6.4 Adolescents
  • 6.5 Young adults
  • 6.6 Adults

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Becton, Dickinson and Company
  • 9.3 Biomerieux
  • 9.4 Bio-Rad Laboratories
  • 9.5 Certest Biotec
  • 9.6 ELITechGroup
  • 9.7 F. Hoffmann-La Roche
  • 9.8 IMMY
  • 9.9 Seegene
  • 9.10 Siemens Healthineers
  • 9.11 Thermo Fisher Scientific
  • 9.12 Uniogen